(Date:12/1/2008)...M, Wisc., Dec. 1 Mach On...olutions company that develops products,that prod...al and consumer,market, announced today that Mr. ...irectors effective upon the closing of the acquisi... , Mr. Ballantyne is an officer and/or dire...
(Date:12/1/2008)...SVILLE, Md., Dec. 1 Vap...apy products, announced today that President and C... annual health care conference on Wednesday, Decem...ttan. , , The conference brings together p...lth care sectors to present and discuss trends, ad...
(Date:12/1/2008)... , , JOHANNESBURG, South Africa, Dec. 1 /PR...nt from Martha Newsome, director of World Vision I...pe Initiatives: , , This World AIDS Day is ...itating global financial crisis that threatens the...he need for greater interventions to protect child...
(Date:12/1/2008)...APUTO, Mozambique (1 December 2008)Concerned that...funding for projects in developing countries, lead...roup today told a conference that relatively modes...he livelihoods of hundreds of millions of people l...nnual meeting of the Consultative Group on Interna...
Breaking Medicine News(10 mins):Health News:Mr. Tad Ballantyne to Join Mach One Board of Directors 2Health News:Global Financial Crisis Fuels Need for Greater HIV and AIDS Assistance for Children 2Health News:Experts: Targeted agricultural investments will yield high results, slash poverty in Africa 2Health News:Experts: Targeted agricultural investments will yield high results, slash poverty in Africa 3Health News:Experts: Targeted agricultural investments will yield high results, slash poverty in Africa 4...gainst bird flu was developed by Peter Palese, cha... of Medicine in New York City//. He said that it i.... It is a vaccine for the poultry and it offers pr...ase. The team of American researchers inserted the...
...ng done on the ecology, blaming wild birds, as the...ess// , says UN Food and Agriculture Organization ...s to Avian flu. Since it can be mutated it can eve...and humans. FAO’s chief veterinary officer, Jose...
...e anti-reservation medicos strike in India, the go... key demand for an experts committee on quota in c...nd doctors rejected the overture and decided to in...dh in Delhi on May 31. On a day of hectic negotia...
...ed, scores of heroin addicts hobble around the cro...ue de-addiction programme in this Manipur district...heavy China-made padlocks that are difficult to pi...e ankles of 74 druggies as they shamble across the...
Other Medicine News:Health News:Heroin Addicts Chained For Cure 2Health News:Heroin Addicts Chained For Cure 3Health News:Heroin Addicts Chained For Cure 4(Date:11/25/2008)... Proteolix, Inc., a,leader in the...hat target,protein degradation pathways in cancer...ta from two ongoing Phase 2 clinical trials of car... the upcoming 50th Annual Meeting of the,American...first in a new class,of specific proteasome inhib...
(Date:11/25/2008)...Call/ -- CardioVascular,BioTherapeutics, Inc. (OT...as,dosed the first patient in North America (NA) ...reat patients with severe coronary heart disease. ...nary heart Disease) trial will include,four rando...pproximately 120,patients with severe coronary he...
(Date:11/24/2008)...ess Month , , Oak Brook, Ill., Nov. 24 /PRN...astrointestinal Endoscopy (ASGE) and the Pancreati...er to raise awareness about pancreatic cancer, edu...s that are available for them. , , Pancreat...aths in the U.S. In 2008, an estimated 37,680 Amer...
(Date:11/24/2008)...ll/ - Predictive medicine company PreMD Inc. (TSX:...d into a fully funded collaborative clinical study...s. PreMD,s PREVU* skin cholesterol test will be us...,s skin care products in a European clinical study...ed by PreMD with the cosmetic company. , "This ...
Breaking Medicine Technology:Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate 2NutritionQuests Alive 21 Program Improves Quality of Life 30222 1NutritionQuests Alive 21 Program Improves Quality of Life 30222 2InCode BioPharmaceutics Appoints New President and CEO 9268 1InCode BioPharmaceutics Appoints New President and CEO 9268 2PacificGMP and Actinium Pharmaceuticals Announce Agreements for cGMP Antibody Manufacturing and Stability Testing 9266 1PacificGMP and Actinium Pharmaceuticals Announce Agreements for cGMP Antibody Manufacturing and Stability Testing 9266 2STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer 28R 29 Material for Accommodating Intraocular Lenses 30218 1STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer 28R 29 Material for Accommodating Intraocular Lenses 30218 2STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer 28R 29 Material for Accommodating Intraocular Lenses 30218 3STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer 28R 29 Material for Accommodating Intraocular Lenses 30218 4STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer 28R 29 Material for Accommodating Intraocular Lenses 30218 5...SS WIRE)--May 24, 2007 - ImmunoGen, Inc.,(Nasdaq: ...argeted,anticancer therapeutics using its Tumor-Ac...that clinical findings for three,different TAP com...,reported at the 43rd American Society of Clinical... 1-5, 2007 in Chicago, IL., Trastuzumab-DM1 (abstr...
...SS WIRE)--May 25, 2007 - ARIAD,Pharmaceuticals, In...vestigators from leading cancer centers will prese...s of the Company,s novel mTOR,inhibitor, AP23573, ...linical Oncology (ASCO) in Chicago, Illinois, on S...e 2 trial of single-agent,AP23573 in patients with...
Other Medicine Technology:ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 2ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 3Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 2Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 3Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 4The Finnpipette BioControl multichannel has the same innovative features as the single channel model.The same universal handle fits all seven multichannel and five single channel tip cone modules. Bo
... The new Finnpipette Novus is so user-friendly tha.... With the intuitive instantly familiar menu and s...ing functions you need quickly and easily. The lar...ll names of all functions. The easily accessible ...
...ntire Column of a 384 Well Plate at Once , To inc...es, you need a pipettor that can adapt to the narr...ur 16-channel Impact pipettor., Available with Im...s innovation was specifically designed to allow yo...
The Seal-Away CS and Alliance Catheter Delivery System introducers are designed for the introduction of catheters or devices into the coronary sinus from a superior approach. These introducers combin
Medicine Products: